Page last updated: 2024-09-05

l 163191 and l 692429

l 163191 has been researched along with l 692429 in 8 studies

Compound Research Comparison

Studies
(l 163191)
Trials
(l 163191)
Recent Studies (post-2010)
(l 163191)
Studies
(l 692429)
Trials
(l 692429)
Recent Studies (post-2010) (l 692429)
350174051

Protein Interaction Comparison

ProteinTaxonomyl 163191 (IC50)l 692429 (IC50)
Growth hormone secretagogue receptor type 1Rattus norvegicus (Norway rat)0.06
Type-1 angiotensin II receptorHomo sapiens (human)3.6
Growth hormone secretagogue receptor type 1Homo sapiens (human)2.8
Growth hormone secretagogue receptor type 1Sus scrofa (pig)0.063

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (37.50)18.2507
2000's4 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Chaung, LY; Dean, DC; Ellsworth, RL; Griffin, P; Melillo, DG; Nargund, RP; Patchett, AA; Pong, SS; Smith, RG; Van der Ploeg, LH1
Bach, MA; Murphy, MG; Nargund, RP; Patchett, AA; Smith, RG1
Chan, WW; Cheng, K; Jacks, T; Morriello, G; Patchett, AA; Prendergast, K; Schleim, KD; Smith, RG; Yang, L1
Hourai, S; Hume, WE; Kumagai, K; Nagamine, J; Nagata, R; Noguchi, H; Okazaki, K; Seki, H; Taiji, M; Tokunaga, T; Ueki, Y; Umezome, T1
Butler, B; Chan, WW; Cheng, K; Hickey, G; Jacks, TM; Lu, Z; Patchett, AA; Schleim, KD; Tata, JR; Wei, L1
Ankersen, M; Bondensgaard, K; Bywater, RP; Hansen, BS; Thøgersen, H; Wulff, BS1
Bach, A; Brandt, E; Heding, A; Holst, B; Schwartz, TW1
Bukhari, SNA1

Reviews

2 review(s) available for l 163191 and l 692429

ArticleYear
Peptidomimetic growth hormone secretagogues. Design considerations and therapeutic potential.
    Journal of medicinal chemistry, 1998, Aug-13, Volume: 41, Issue:17

    Topics: Amino Acid Sequence; Animals; Drug Design; Growth Hormone-Releasing Hormone; Hormones; Human Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Molecular Sequence Data; Oligopeptides; Protein Conformation; Receptors, Somatotropin

1998
An insight into the multifunctional role of ghrelin and structure activity relationship studies of ghrelin receptor ligands with clinical trials.
    European journal of medicinal chemistry, 2022, May-05, Volume: 235

    Topics: Animals; Clinical Trials as Topic; Ghrelin; Growth Hormone; Ligands; Peptidomimetics; Receptors, Ghrelin; Structure-Activity Relationship

2022

Other Studies

6 other study(ies) available for l 163191 and l 692429

ArticleYear
Development of a high specific activity sulfur-35-labeled sulfonamide radioligand that allowed the identification of a new growth hormone secretagogue receptor.
    Journal of medicinal chemistry, 1996, Apr-26, Volume: 39, Issue:9

    Topics: Amino Acid Sequence; Animals; Indoles; Molecular Sequence Data; Radioligand Assay; Rats; Receptors, Somatotropin; Spiro Compounds; Sulfonamides; Sulfur Radioisotopes

1996
Potent 3-spiropiperidine growth hormone secretagogues.
    Bioorganic & medicinal chemistry letters, 1998, Jan-06, Volume: 8, Issue:1

    Topics: Animals; Growth Hormone; In Vitro Techniques; Indoles; Piperidines; Pituitary Gland; Rats; Spiro Compounds; Structure-Activity Relationship

1998
Oxindole derivatives as orally active potent growth hormone secretagogues.
    Journal of medicinal chemistry, 2001, Dec-20, Volume: 44, Issue:26

    Topics: Administration, Oral; Animals; Biological Availability; Body Weight; CHO Cells; Cricetinae; Crystallography, X-Ray; Ethylamines; Female; Growth Hormone; Human Growth Hormone; Humans; In Vitro Techniques; Indoles; Male; Models, Molecular; Molecular Conformation; Pituitary Gland, Anterior; Rats; Rats, Inbred F344; Rats, Wistar; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Ghrelin; Stereoisomerism; Structure-Activity Relationship

2001
Substituted bridged phenyl piperidines: orally active growth hormone secretagogues.
    Bioorganic & medicinal chemistry letters, 2003, May-19, Volume: 13, Issue:10

    Topics: Administration, Oral; Animals; Biological Availability; Dogs; Growth Hormone; Piperidines; Pituitary Gland; Rats; Structure-Activity Relationship

2003
Recognition of privileged structures by G-protein coupled receptors.
    Journal of medicinal chemistry, 2004, Feb-12, Volume: 47, Issue:4

    Topics: Amino Acid Sequence; Animals; Binding Sites; Biphenyl Compounds; Cell Line; Conserved Sequence; Cricetinae; Indans; Indoles; Ligands; Models, Molecular; Molecular Sequence Data; Piperidines; Receptor, Angiotensin, Type 1; Receptor, Melanocortin, Type 4; Receptors, G-Protein-Coupled; Receptors, Ghrelin; Receptors, Serotonin; Sequence Alignment; Spiro Compounds; Tetrazoles

2004
Nonpeptide and peptide growth hormone secretagogues act both as ghrelin receptor agonist and as positive or negative allosteric modulators of ghrelin signaling.
    Molecular endocrinology (Baltimore, Md.), 2005, Volume: 19, Issue:9

    Topics: Allosteric Regulation; Amino Acid Sequence; Animals; Arrestin; Benzazepines; Calcium; CREB-Binding Protein; Ghrelin; Humans; Indoles; Inositol Phosphates; Molecular Sequence Data; Molecular Structure; Oligopeptides; Peptide Hormones; Receptors, G-Protein-Coupled; Receptors, Ghrelin; Response Elements; Serum Response Element; Signal Transduction; Spiro Compounds; Tetrazoles; Transcription, Genetic

2005